MedTrace Logo

Identification of Markers of Post-Traumatic Stress Disorder (PTSD) Relapse

NCT01545505 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2013-02-21

No results posted yet for this study

Summary

Relapse of post-traumatic stress disorder (PTSD) remains challenging. In addition, factors predicting PTSD relapse are still unknown. The aim of this study is to examine whether clinical and neuropsychological changes (e.g., attentional bias toward aversive cues) that characterized PTSD can be observed in people with past PTSD (children and their families) and whether these persistent changes are predictive of PTSD relapse.

Conditions

  • Post Traumatic Stress Disorder (PTSD)

Interventions

BEHAVIORAL

Neuropsychological assessment

A clinical evaluation with Impact of Events Scale-Revised, Child Post-Traumatic Stress Reaction Index, State-Trait Anxiety Inventory for Children, Children Depression Inventory and Emotion, activity and sociability. A neuropsychological assessment with a emotional Go-No/Go, a visual search task, the Trail Making Test, 3 items of the WISC III ( and the Grober and Buschke Test.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Principal Investigators

  • Michel BENOIT, M.D.,PhD · Psychiatrie, Hôpital Pasteur, CHU de NICE

  • Wissam EL HAGE, M.D, PhD · Psychiatrie, CHU de TOURS

  • Frédérique JOVER, M.D. · CAP, Hôpital St ROCH, CHU de NICE

  • Florence ASKENAZY, M.D. · Fondation Lenval, NICE

  • Philippe BIRMES, M.D. · Psychiatrie, CHU de TOULOUSE

  • Virginie BUISSE, M.D. · CAP, Hôpital St Roch, CHU de NICE

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-10-31
Completion
2014-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01545505 on ClinicalTrials.gov